These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 15754307

  • 1. Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo.
    Zavaglia D, Lin EH, Guidetti M, Pluquet O, Hainaut P, Favrot MC, Coll JL.
    J Gene Med; 2005 Jul; 7(7):936-44. PubMed ID: 15754307
    [Abstract] [Full Text] [Related]

  • 2. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
    Hakkarainen T, Wahlfors T, Meriläinen O, Loimas S, Hemminki A, Wahlfors J.
    J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
    [Abstract] [Full Text] [Related]

  • 3. VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo.
    Zender L, Kühnel F, Köck R, Manns M, Kubicka S.
    Cancer Gene Ther; 2002 Jun; 9(6):489-96. PubMed ID: 12032659
    [Abstract] [Full Text] [Related]

  • 4. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
    Sheridan PJ, Lawrie A, Crossman DC, Holt CM, Newman CM.
    J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
    [Abstract] [Full Text] [Related]

  • 5. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
    Liu CS, Kong B, Xia HH, Ellem KA, Wei MQ.
    J Gene Med; 2001 Mar; 3(2):145-52. PubMed ID: 11318113
    [Abstract] [Full Text] [Related]

  • 6. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.
    Zavaglia D, Favrot MC, Eymin B, Tenaud C, Coll JL.
    Gene Ther; 2003 Feb; 10(4):314-25. PubMed ID: 12595890
    [Abstract] [Full Text] [Related]

  • 7. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.
    Roy I, Holle L, Song W, Holle E, Wagner T, Yu X.
    Anticancer Res; 2002 Feb; 22(6A):3185-9. PubMed ID: 12530063
    [Abstract] [Full Text] [Related]

  • 8. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
    Xiong F, Xiao S, Yu M, Li W, Zheng H, Shang Y, Peng F, Zhao C, Zhou W, Chen H, Fang L, Chamberlain JS, Zhang C.
    BMC Neurosci; 2007 Jul 08; 8():50. PubMed ID: 17617925
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells.
    Fang B, Xu B, Koch P, Roth JA.
    Gene Ther; 1998 Oct 08; 5(10):1420-4. PubMed ID: 9930348
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene.
    Wybranietz WA, Gross CD, Phelan A, O'Hare P, Spiegel M, Graepler F, Bitzer M, Stähler P, Gregor M, Lauer UM.
    Gene Ther; 2001 Nov 08; 8(21):1654-64. PubMed ID: 11895004
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation.
    Chhabra A, Mehrotra S, Chakraborty NG, Mukherji B, Dorsky DI.
    Eur J Immunol; 2004 Oct 08; 34(10):2824-33. PubMed ID: 15368298
    [Abstract] [Full Text] [Related]

  • 19. Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficiencies.
    Lemken ML, Graepler F, Wolf C, Wybranietz WA, Smirnow I, Schmidt U, Gregor M, Bitzer M, Lauer UM.
    Int J Oncol; 2007 May 08; 30(5):1153-61. PubMed ID: 17390017
    [Abstract] [Full Text] [Related]

  • 20. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting.
    Aints A, Güven H, Gahrton G, Smith CI, Dilber MS.
    Gene Ther; 2001 Jul 08; 8(14):1051-6. PubMed ID: 11526452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.